Cargando…

Exposure to glyphosate and risk of non-Hodgkin lymphoma and multiple myeloma: an updated meta-analysis

OBJECTIVE: We carried out a systematic review and meta-analysis of epidemiologic studies on the association between occupational exposure to glyphosate and risk of non-Hodgkin lymphoma (NHL) and multiple myeloma (MM). METHODS: We conducted a systematic search of the literature, and identified 18 rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Donato, Francesca, Pira, Enrico, Ciocan, Catalina, Boffetta, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 srl 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809965/
https://www.ncbi.nlm.nih.gov/pubmed/32096774
http://dx.doi.org/10.23749/mdl.v111i1.8967
_version_ 1783637224125890560
author Donato, Francesca
Pira, Enrico
Ciocan, Catalina
Boffetta, Paolo
author_facet Donato, Francesca
Pira, Enrico
Ciocan, Catalina
Boffetta, Paolo
author_sort Donato, Francesca
collection PubMed
description OBJECTIVE: We carried out a systematic review and meta-analysis of epidemiologic studies on the association between occupational exposure to glyphosate and risk of non-Hodgkin lymphoma (NHL) and multiple myeloma (MM). METHODS: We conducted a systematic search of the literature, and identified 18 relevant publications, from which we extracted results from seven non-overlapping studies of NHL and three of MM. We performed random-effects meta-analyses for ever-exposure to glyphosate, dose-response, and risk of specific NHL subtypes. RESULTS: The meta-relative risk (RR) of NHL was 1.03 (95% confidence interval [CI] 0.86-1.21), that of MM was 1.04 (95% CI 0.67-1.41). The meta-RR of NHL for highest category of exposure was 1.49 (95% CI 0.37-2.61; 3 studies). The meta-RR for diffuse large B-cell lymphoma (DLBCL) was 1.31 (95% CI 0.93-1.75); that for follicular lymphoma was 0.82 (95% CI 0.93-1.70), and that for chronic lymphocytic leukemia was 0.85 (95% CI 0.20-1.49). There was indication of publication bias for studies on NHL. CONCLUSIONS: Our meta-analysis provided no overall evidence of an increased risk for both NHL and MM in subjects occupationally exposed to glyphosate. In secondary analyses we detected a small increase in risk for the category with highest level of exposure as well as for DLBCL. The evidence of publication bias suggests caution in the interpretation of the results.
format Online
Article
Text
id pubmed-7809965
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Mattioli 1885 srl
record_format MEDLINE/PubMed
spelling pubmed-78099652021-01-29 Exposure to glyphosate and risk of non-Hodgkin lymphoma and multiple myeloma: an updated meta-analysis Donato, Francesca Pira, Enrico Ciocan, Catalina Boffetta, Paolo Med Lav Original Article OBJECTIVE: We carried out a systematic review and meta-analysis of epidemiologic studies on the association between occupational exposure to glyphosate and risk of non-Hodgkin lymphoma (NHL) and multiple myeloma (MM). METHODS: We conducted a systematic search of the literature, and identified 18 relevant publications, from which we extracted results from seven non-overlapping studies of NHL and three of MM. We performed random-effects meta-analyses for ever-exposure to glyphosate, dose-response, and risk of specific NHL subtypes. RESULTS: The meta-relative risk (RR) of NHL was 1.03 (95% confidence interval [CI] 0.86-1.21), that of MM was 1.04 (95% CI 0.67-1.41). The meta-RR of NHL for highest category of exposure was 1.49 (95% CI 0.37-2.61; 3 studies). The meta-RR for diffuse large B-cell lymphoma (DLBCL) was 1.31 (95% CI 0.93-1.75); that for follicular lymphoma was 0.82 (95% CI 0.93-1.70), and that for chronic lymphocytic leukemia was 0.85 (95% CI 0.20-1.49). There was indication of publication bias for studies on NHL. CONCLUSIONS: Our meta-analysis provided no overall evidence of an increased risk for both NHL and MM in subjects occupationally exposed to glyphosate. In secondary analyses we detected a small increase in risk for the category with highest level of exposure as well as for DLBCL. The evidence of publication bias suggests caution in the interpretation of the results. Mattioli 1885 srl 2020 2020-02-24 /pmc/articles/PMC7809965/ /pubmed/32096774 http://dx.doi.org/10.23749/mdl.v111i1.8967 Text en Copyright: © 2020 ACTA BIO MEDICA SOCIETY OF MEDICINE AND NATURAL SCIENCES OF PARMA http://creativecommons.org/licenses/by-nc-sa/4.0 This work is licensed under a Creative Commons Attribution 4.0 International License
spellingShingle Original Article
Donato, Francesca
Pira, Enrico
Ciocan, Catalina
Boffetta, Paolo
Exposure to glyphosate and risk of non-Hodgkin lymphoma and multiple myeloma: an updated meta-analysis
title Exposure to glyphosate and risk of non-Hodgkin lymphoma and multiple myeloma: an updated meta-analysis
title_full Exposure to glyphosate and risk of non-Hodgkin lymphoma and multiple myeloma: an updated meta-analysis
title_fullStr Exposure to glyphosate and risk of non-Hodgkin lymphoma and multiple myeloma: an updated meta-analysis
title_full_unstemmed Exposure to glyphosate and risk of non-Hodgkin lymphoma and multiple myeloma: an updated meta-analysis
title_short Exposure to glyphosate and risk of non-Hodgkin lymphoma and multiple myeloma: an updated meta-analysis
title_sort exposure to glyphosate and risk of non-hodgkin lymphoma and multiple myeloma: an updated meta-analysis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809965/
https://www.ncbi.nlm.nih.gov/pubmed/32096774
http://dx.doi.org/10.23749/mdl.v111i1.8967
work_keys_str_mv AT donatofrancesca exposuretoglyphosateandriskofnonhodgkinlymphomaandmultiplemyelomaanupdatedmetaanalysis
AT piraenrico exposuretoglyphosateandriskofnonhodgkinlymphomaandmultiplemyelomaanupdatedmetaanalysis
AT ciocancatalina exposuretoglyphosateandriskofnonhodgkinlymphomaandmultiplemyelomaanupdatedmetaanalysis
AT boffettapaolo exposuretoglyphosateandriskofnonhodgkinlymphomaandmultiplemyelomaanupdatedmetaanalysis